I don't disagree on that point and can understand.. frustrating still
as for Q1 of 2022 we can also expect an update on 1801 with phase 2 to kick off, so that will be an ann in itself when they get that underway.
Phase 3 planning for 1503 "underway" - what ever that means - No real time line commited to within the document.
as for the canine study, we should actually see results pretty quickly as the testing is to occur on a total of 45 dogs, with 28 day treatment course in total with 2 applications a day.. so should that kick off in 1st half of 22 we should have results pretty quickly and before mid year one would hope.
as you said - one for the back pocket and to be forgotten about in the interim
Ann: Botanix Roadshow Presentation, page-5
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 410003 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 346713 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |